S. Grundy

Endocrinology, Diabetes and Metabolism · 2000–2020

A researcher in the Science corpus: 45 papers; trusts 39 researchers and is trusted by 6 researchers here, as inferred from the citation graph.

Subfields

Whom S. Grundy trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. E. Ford
  2. P. Ridker
  3. J. Despres
  4. Peter W. F. Wilson
  5. Gerald I. Shulman
  6. H. Buchwald
  7. W. Knowler
  8. G. Boden
  9. W. Giles
  10. A. Berg

Who trusts S. Grundy overall

  1. Jaspinder Kaur
  2. E. Ford
  3. S. Hyman
  4. V. Basevi
  5. J. Despres
  6. Marc A. F. De Hert
  7. P. Ridker
  8. U. Galicia-Garcia
  9. R. Ervin
  10. E. Kassi

Papers from S. Grundy's perspective

Ordered by how strongly the researchers S. Grundy trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. (New England Journal of Medicine)
  2. Reprint: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. (Journal of the American Pharmacists Association)
  3. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. (Diabetes Care)
  4. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. (Journal of the American Medical Association (JAMA))
  5. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans (Nature Genetics)
  6. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. (New England Journal of Medicine)
  7. Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study (Circulation)
  8. Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids (Nature)
  9. Lifetime risk for diabetes mellitus in the United States. (Journal of the American Medical Association (JAMA))
  10. Lipoprotein(a) as a cardiovascular risk factor: current status (European Heart Journal)

Their papers